Indexed In
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- ResearchBible
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Proquest Summons
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- MIAR
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Articles published in Journal of Pharmacogenomics & Pharmacoproteomics have been cited by esteemed scholars and scientists all around the world. Journal of Pharmacogenomics & Pharmacoproteomics has got h-index 12, which means every article in Journal of Pharmacogenomics & Pharmacoproteomics has got 12 average citations.
Following are the list of articles that have cited the articles published in Journal of Pharmacogenomics & Pharmacoproteomics.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
30 | 30 | 13 | 4 | 7 |
Year wise citations received |
59 | 69 | 60 | 48 | 62 |
| Journal total citations count | 548 |
| Journal Impact Factor | 2.31 |
| Journal 5 years Impact Factor | 3.74 |
| Journal CiteScore | 4.86 |
| Journal h-index | 12 |
Important citations
Statins and the neuromuscular system: a neurologist's perspective
The risk of hepatotoxicity, new onset diabetes and rhabdomyolysis in the era of high-intensity statin therapy: does statin type matter?
The future of pharmaceutical manufacturing in the context of the scientific, social, technological and economic evolution
Inhibition of Intestinal OATP2B1 by the Calcium Receptor Antagonist Ronacaleret Results in a Significant Drug-Drug Interaction by Causing a 2-Fold Decrease in Exposure of Rosuvastatin
A pharmacometabonomic approach to predicting metabolic phenotypes and pharmacokinetic parameters of atorvastatin in healthy volunteers
SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population
Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders
Brief report: Tempol, a novel antioxidant, inhibits both activated T cell and antigen presenting cell derived cytokines in-vitro from COVID-19 patients
Investigations into the significance of Nrf2 signalling and ubiquitination of proteins in Respiratory Syncytial Virus infection
Impact of Cardiovascular Diseases on COVID-19: A Systematic Review
Evaluation of oxidative stress level: total antioxidant capacity, total oxidant status and glutathione activity in patients with Covid-19
ER stress protein PERK promotes inappropriate innate immune responses and pathogenesis during RSV infection
Nrf2 Activator PB125® as a Carnosic Acid-Based Therapeutic Agent against Respiratory Viral Diseases, including COVID-19
Trend Analysis of Superoxide Dismutase 3 (SOD3) and Reactive Oxygen Species (ROS) levels on BioSmart and Safe Bus Passengers
The comparison of oxidative markers between Covid-19 patients and healthy subjects: oxidative stress and Covid-19
Antioxidants and COVID-19.
Usefulness of oxidative stress marker evaluation at admission to the intensive care unit in patients with COVID-19
Antioxidants and COVID-19
Use of Antioxidants for the Neuro-Therapeutic Management of COVID-19
Intracellular Redox-Modulated Pathways as Targets for Effective Approaches in the Treatment of Viral Infection